Evidence map›Paper›PMID 32730263›Full record

ArticlePloS one2020

Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.

Kaiyu Jiang, Haeja Kessler, Yungki Park, Marc Sudman, Susan D Thompson, James N Jarvis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Reduced Expression of mInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kaiyu JiangDepartment of Pediatrics, Pediatric Rheumatology Research, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States of America.
Haeja KesslerDepartment of Pediatrics, Pediatric Rheumatology Research, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States of America.
Yungki ParkDepartment of Biochemistry, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States of America.
Marc SudmanCenter for Autoimmune Genetics & Epigenetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
Susan D ThompsonCenter for Autoimmune Genetics & Epigenetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
James N JarvisDepartment of Pediatrics, Pediatric Rheumatology Research, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States of America.ORCID 0000-0002-1878-0717
University at Buffalo, State University of New York · USCincinnati Children's Hospital Medical Center · USJacobs (United States) · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Transcription mechanism of Myrf for central nervous system myelinationR01NS094181 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PARK, YUNGKI · 2015 to 2019
$1.8M
Role of oligodendrocyte enhancers in central nervous system development and diseaseR21NS102558 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PARK, YUNGKI · 2018 to 2019
$439k
Identifying Causal Variants in Juvenile Arthritis Using a Massively Parallel Reporter AssayR21AR071878 · NIAMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI JARVIS, JAMES N · 2018 to 2019
$386k
NCATS NIH HHS UL1 TR001412NIAMS NIH HHS R21 AR071878NINDS NIH HHS R01 NS094181NINDS NIH HHS R21 NS102558
6 · The paper itself

Abstract

objectiveThe risk loci for juvenile idiopathic arthritis (JIA) consist of extended haplotypes that include functional elements in addition to canonical coding genes. As with most autoimmune diseases, the risk haplotypes for JIA are highly enriched for H3K4me1/H3K27ac histone marks, epigenetic signatures that typically identify poised or active enhancers. In this study, we test the hypothesis that genetic risk for JIA is exerted through altered enhancer-mediated gene regulation.

methodsWe mined publically available HiC and other chromatin conformation data to determine whether H3K27ac-marked regions in 25 JIA risk loci showed physical evidence of contact with gene promoters. We also used in vitro reporter assays to establish as proof-of-concept the idea that genetic variants in linkage disequilibrium with GWAS-identified tag SNPs alter enhancer function.

resultsAll 25 loci examined showed multiple contact sites in the 4 different cell lines that we queried. These regions were characterized by HiC-defined loop structures that included 237 immune-related genes. Using in vitro assays, we found that a 657 bp, H3K4me1/H3K27-marked region within the first intron of IL2RA shows enhancer activity in reporter assays, and this activity is attenuated by SNPs on the IL2RA haplotype that we identified using whole genome sequencing of children with JIA. Similarly, we identified a 1,669 bp sequence in an intergenic region of the IL6R locus where SNPs identified in children with JIA increase enhancer function in reporter assays.

conclusionsThese studies provide evidence that altered enhancer function contributes to genetic risk in JIA. Further studies to identify the specific target genes of genetically altered enhancers are warranted.

Indexed as

Chromatin Assembly and DisassemblyEnhancer Elements, GeneticPolymorphism, Single NucleotideArthritis, JuvenileHistonesHumansK562 CellsQuantitative Trait LociTHP-1 CellsHistones

Identifiers

PMID32730263
PMCPMC7392255
OpenAlexW3046755101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.